|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.390 HKD | -4.24% |
|
+1.19% | +171.20% |
| 03-30 | Jinhai Medical Technology's 2025 Loss Narrows; Shares Drop 12% | MT |
| 03-27 | Jinhai Medical Technology Limited Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Products | 1.56M | 656K | 20.43M | 25.93M | 29.96M | |||||
Total Assets | 7.72M | 12.4M | 23.72M | 19.78M | 55.44M | |||||
Interest Expense | -7.48K | -24.69K | -56K | -246K | -179K | |||||
Income Tax Expense | 1.18K | 25.2K | 28K | - | 141K | |||||
CAPEX | - | -2.6M | -1.06M | -147K | -3K | |||||
EBT | -754K | -704K | -2.18M | -3.64M | -2.09M | |||||
D&A | 58.06K | 317K | 651K | 778K | 1.21M | |||||
Net Income | -755K | -729K | -2.21M | -3.64M | -2.23M | |||||
Human Resources and Personnel Management | ||||||||||
Services | 19.86M | 21.62M | 25.21M | 24.31M | 16.31M | |||||
Total Assets | 20.46M | 24.26M | 31.93M | 34.87M | 30.02M | |||||
Interest Expense | -79.66K | -27.13K | -126K | -424K | -417K | |||||
Income Tax Expense | 434K | 643K | 867K | 28K | 92K | |||||
CAPEX | - | -3.22M | - | -166K | -92K | |||||
EBT | 2.85M | 3.92M | 1.91M | 1.7M | -3.51M | |||||
D&A | 5M | 3.77M | 3.11M | 3.63M | 2.89M | |||||
Net Income | 2.42M | 3.27M | 1.04M | 1.67M | -3.61M | |||||
Staffing & Outsourcing Services | - | - | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Net Income | -2.13M | -2.43M | -2.95M | -16.28M | -11.56M | |||||
D&A | 305K | 301K | 339K | 610K | 522K | |||||
EBT | -2.13M | -2.43M | -2.95M | -16.28M | -11.56M | |||||
CAPEX | - | -547K | -196K | -675K | - | |||||
Interest Expense | -45.17K | -9.89K | -39K | -103K | -79K | |||||
Total Assets | 5.51M | 3.61M | 6.57M | 4.22M | 3.38M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
The People's Republic of China ("The PRC") | 1.56M | - | 20.43M | 25.93M | 29.99M | |||||
Total Assets | 581K | - | - | 4.38M | - | |||||
Total Assets | - | 468K | 1.36M | 1.48M | 1.15M | |||||
Singapore | 19.86M | 21.62M | 25.21M | 15.9M | 13.36M | |||||
Total Assets | 464K | 1.28M | 13.39M | 22.27M | 19.64M | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Unallocated | - | - | - | 8.42M | 2.92M | |||||
Mainland China | - | 656K | - | - | - | |||||
Total Assets | - | 5.06M | 4.19M | - | 3.06M |
- Stock Market
- Equities
- 2225 Stock
- Financials Jinhai Medical Technology Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition